Product-market fit in regulated industries means buyers can legally deploy your AI and get paid value from it. For AI startups, fit means clearance plus workflow adoption plus ongoing monitoring, not just user demand. A pilot is not fit. Fit arrives when compliance, safety evidence, and operations all pass at a paying customer.
Table of Contents
- Why traction alone is not fit
- How health startups clear the first gate
- What bank and lending buyers demand
- How to sequence Europe and real adoption
Why traction alone is not fit
A consumer app can grow first and fix controls later. A health or bank customer cannot. Legal deployment is part of the product. That shifts discovery. How health startups clear the first gate
In health AI, FDA marketing authorization is the practical entry ticket. The FDA states it has authorized over 1,600 AI-enabled medical devices for U.S. marketing as of September 2026, described in the FDA list of authorized devices. Pick a narrow intended use and clinical workflow. A triage aid for one scan type clears review faster than a broad diagnostic platform. It also simplifies validation at hospitals. Plan updates before launch. FDA finalized Predetermined Change Control Plan guidance in December 2024, according to a Clarkston Consulting summary, letting sponsors pre-specify model changes in 510(k), De Novo or PMA submissions, detailed in the Clarkston summary of the FDA guidance. Use that path to avoid a new submission for each qualifying improvement. Banks buy proof of control, not model skill alone. The Federal Reserve, OCC and FDIC issued revised model-risk guidance SR 26-2 on April 17, 2026, requiring proof that models are conceptually sound, independently validated and monitored, published in the Federal Reserve supervision letter. Expect the bank to ask for data sources, limits, test results, owner roles, and monitoring plans. Fintech vendors inherit those duties when they sell into banks. Provide validation reports and change logs with the sales deck. Design for explanation from day one:. Treat EU timing as a roadmap constraint. The European Commission service desk phases standalone high-risk AI duties from Dec. 2, 2027 and embedded-product AI duties from Aug. 2, 2028, shown on the European Commission AI Act timeline. Do not wait to build conformity files. Draft intended purpose, risk review, data controls, test evidence, and postmarket checks now. Sell first where your current proof already meets buyer rules. Measure fit by deployment, not demos. Count live sites, weekly active clinicians or officers, time saved, error reduction, and audit pass rate. Require one reference customer to expand from pilot to paid units before scaling sales hiring.What bank and lending buyers demand
How to sequence Europe and real adoption
You Might Also Like